Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2003-11-4
pubmed:abstractText
The type V TGF-beta receptor (TbetaR-V)/IGFBP-3 receptor mediates the IGF-independent growth inhibition induced by IGFBP-3. It also mediates the growth inhibitory response to TGF-beta1 in concert with other TGF-beta receptor types, and its loss may contribute to the malignant phenotype of human carcinoma cells. Here we demonstrate that TbetaR-V is identical to LRP-1/alpha2M receptor as shown by MALDI-TOF analysis of tryptic peptides of TbetaR-V purified from bovine liver. In addition, 125I-IGFBP-3 affinity-labeled TbetaR-V in Mv1Lu cells is immunoprecipitated by antibodies to LRP-1 and TbetaR-V. RAP, an LRP-1 antagonist, inhibits binding of 125I-TGF-beta1 and 125I-IGFBP-3 to TbetaR-V and diminishes IGFBP-3-induced growth inhibition in Mv1Lu cells. Absent or low levels of LRP-1, as with TbetaR-V, have been linked to the malignant phenotype of carcinoma cells. Mutagenized Mv1Lu cells selected for reduced expression of LRP-1 have an attenuated growth inhibitory response to TGF-beta1 and IGFBP-3. LRP-1-deficient mouse embryonic fibroblasts lack a growth inhibitory response to TGF-beta1 and IGFBP-3. On the other hand, stable transfection of H1299 human lung carcinoma cells with LRP-1 cDNA restores the growth inhibitory response. These results suggest that the LRP-1/TbetaR-V/IGFBP-3 receptor is required for the growth inhibitory response to IGFBP-3 and TGF-beta1.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1530-6860
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2068-81
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:14597676-Animals, pubmed-meshheading:14597676-Carcinoma, pubmed-meshheading:14597676-Cattle, pubmed-meshheading:14597676-Cell Division, pubmed-meshheading:14597676-Cell Line, Tumor, pubmed-meshheading:14597676-Cells, Cultured, pubmed-meshheading:14597676-Humans, pubmed-meshheading:14597676-Insulin-Like Growth Factor Binding Protein 3, pubmed-meshheading:14597676-Liver, pubmed-meshheading:14597676-Low Density Lipoprotein Receptor-Related Protein-1, pubmed-meshheading:14597676-Lung Neoplasms, pubmed-meshheading:14597676-Mice, pubmed-meshheading:14597676-Mice, Knockout, pubmed-meshheading:14597676-Precipitin Tests, pubmed-meshheading:14597676-Receptors, Cell Surface, pubmed-meshheading:14597676-Receptors, Transforming Growth Factor beta, pubmed-meshheading:14597676-Sequence Homology, Amino Acid, pubmed-meshheading:14597676-Transfection, pubmed-meshheading:14597676-Transforming Growth Factor beta, pubmed-meshheading:14597676-Transforming Growth Factor beta1
pubmed:year
2003
pubmed:articleTitle
Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1.
pubmed:affiliation
Department of Biochemistry, Saint Louis University School of Medicine, 1402 South Grand Blvd., St. Louis, Missouri 63104, USA. huangss@slu.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't